Alström syndrome (ALMS) is a rare genetic disorder characterized by a range of symptoms, including progressive hearing loss, vision problems, cardiomyopathy, and metabolic issues such as diabetes ...

R Squared Ltd acquired a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission.

and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 ...

Treatment includes managing symptoms and improving quality of life. Alström syndrome is a rare genetic disorder caused by ALMS1 gene mutations and affects multiple organs and systems. In addition ...

with a drug now in Phase 2 to treat the fibrosis element of Alström Syndrome as a result of such interaction. GlobalData’s analysis ultimately says that orphan drugs face an “uphill battle ...

Treatment includes managing symptoms and improving quality of life. Alström syndrome is a rare genetic disorder caused by ALMS1 gene mutations and affects multiple organs and systems. In addition to ...

Dark underarms may simply have to do with pigmentation and levels of melanin in the skin. But sometimes armpit discoloration ...

Most studies researching childhood obesity focus on the measurement of anthropometric characteristics, predominantly body weight and BMI, as the best phenotypic markers of obesity or risk for ...

After hours: January 31 at 4:08:56 PM EST Loading Chart for RYTM ...